Trellus Health plc
Company Profile
Company website
Sector
Health Care Providers (Health Care Services)
Description
Trellus Health is pioneering a scientifically validated, resilience-driven personalized connected health solution which addresses the intersection of chronic disease with mental health, estimated to cost the US economy $3.7 trillion annually1. Trellus’ approach transforms chronic disease management and changes the lives of patients living with debilitating, incurable conditions, initially focused on Inflammatory Bowel Disease (“IBD”), including Crohn's Disease and ulcerative colitis, and shortly Irritable Bowel Syndrome (“IBS”) but with potential utility and demand across many chronic conditions.
Not all Walbrook clients have a handy 2 page summary available. Click on "Register your interest" and we'll let the Company know that you think this would be useful

Latest Company Summary
Investor Access
02
Oct
Event information
The Company will be announcing its interim results for the six months ended 30 June 2023 on Thursday 28 September 2023.
Investors can sign up to Investor Meet Company for free and add to meet Trellus Health plc via the following link (for the Investor presentation on 2 October 2023):
https://www.investormeetcompany.com/trellus-health-plc/register-investorVenue
Online
Time
Monday, 2 October 2023 at 5:00pm BST
Financial Calendar
Event | Date |
Year End | 31 December |
Half Year End | 30 June |
Preliminary Results* | March / April |
Interim Results* | September |
AGM* | June |
* Months based on previous announcements of this kind